Subclinical hyperthyroidism: Current concepts and scintigraphic imaging

Clinical Nuclear Medicine

Volumn 36, Issue 9, 2011, Pages

  Intenzo, Charles ^a   Jabbour, Serge ^b   Miller, Jeffrey L ^b   Ahmed, Intekhab ^b   Furlong, Kevin ^b   Kushen, Medina ^a   Kim, Sung M ^a   Capuzzi, David M ^b  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

hyperthyroidism; Subclinical; thyrotoxicosis

Indexed keywords

LIOTHYRONINE; PERTECHNETIC ACID TC 99M; PROPYLTHIOURACIL; RADIOACTIVE IODINE; THIAMAZOLE; THYROXINE;

ARTICLE; DISEASE ASSOCIATION; GRAVES DISEASE; HEART SUPRAVENTRICULAR ARRHYTHMIA; HUMAN; HYPERTHYROIDISM; LIOTHYRONINE BLOOD LEVEL; MARINE LENHART SYNDROME; MORTALITY; OSTEOPOROSIS; SUBACUTE THYROIDITIS; SUBCLINICAL HYPERTHYROIDISM; THYROID DISEASE; THYROID NODULE; THYROID SCINTISCANNING; THYROXINE BLOOD LEVEL; TOXIC GOITER;

HUMANS; HYPERTHYROIDISM; IODINE RADIOISOTOPES; RADIONUCLIDE IMAGING;

EID: 80051779914     PISSN: 03639762     EISSN: 15360229     Source Type: Journal    
DOI: 10.1097/RLU.0b013e3182175477     Document Type: Article

References (31)

1. Cooper DS. Approach to the patient with subclinical hyperthyroidism. J Clin Endocrinol Metab. 2007;92:3-9.
2. Surks MI, Ortiz E, Daniels GH, et al. Subclinical thyroid disease: scientific review and guideline for diagnosis and management. JAMA. 2004;291:228-238. (Pubitemid 38082818)
3. Zakarija M, McKenzie J, Banoviac K. Clinical significance of thyroidstimulating antibody in Graves' disease. Ann Intern Med. 1980;93:28-32. (Pubitemid 10071996)
4. Eisenberg B, Arrington ER, Haygood TM, et al. Thyroid scintigraphic patterns, radioactive iodine uptake, and Nuclear Regulatory Commission guidelines for radioiodine use. In: Eisenberg B, ed. Imaging of Thyroid and Parathyroid Glands: A Practical Guide. New York, NY: Churchill Livingstone; 1991:51-57.
5. Harbert JC. Radioiodine therapy of hyperthyroidism. In: Harbert JC, Eckelman WC, Newmann RD, eds. Nuclear Medicine: Diagnosis and Therapy. New York, NY: Thieme Medical; 1996:959-973.
6. Solomon B, Glinoer D, Lagasse R, et al. Current trends in the management of Graves' disease. J Clin Endocrinol Metab. 1990;70:1518-1524.
7. Charkes ND. Graves' disease with functioning nodules (Marine-Lenhart syndrome). J Nucl Med. 1972;13:885-892.
8. Davies TF, Larsen PR. Thyrotoxicosis. In: Larsen PR, Kronenberg HM, Melmed S, et al, eds. Williams Textbook of Endocrinology. 10th ed. Philadelphia, PA: Saunders; 2003:374-455.
9. VanSande J, Lamy F, Lecocq R, et al. Pathogenesis of autonomous thyroid nodules: in vitro study of iodine and adenosine 3′5′-monophosphate metabolism. J Clin Endocrinol Metab. 1988;66:570-589.
10. Goldstein R, Hart JR. Follow-up of solitary autonomous thyroid nodules treated with 131I. N Engl J Med. 1983;309:1473-1476. (Pubitemid 14211570)
11. Clerc J, Dagousset F, Izembart M, et al. Radioiodine therapy of the autonomous thyroid nodule in patients with and without visible extranodular activity. J Nucl Med. 1995;36:217-223.
12. Peter HJ, Gerber H, Studer H, et al. Pathogenesis of heterogeneity in human multinodular goiter. J Clin Invest. 1985;76:1992-2002.
13. VanSoestbergen MJ, Van der Vijver JC, Graafland AD. Recurrence of hyperthyroidism in multinodular goiter after long-term drug therapy: a comparison with Graves' disease. J Endocrinol Invest. 1992;15:797-800. (Pubitemid 23060029)
14. Biondi B, Cooper DS. The clinical significance of subclinical hyperthyroidism. Endocrine Rev. 2008;29:76-131.
15. Volpe R. Subacute thyroiditis. In: Burrow GN, Oppenheimer JH, Volpe R, eds. Thyroid Function and Disease. Philadelphia, PA: Saunders; 1989:179-187.
16. Volpe R. The management of subacute (de Quervain's) thyroiditis. Thyroid. 1993;3:253-257.
17. Hamburger JI. The various presentations of thyroiditis: diagnostic considerations. Ann Intern Med. 1986;104:219-224. (Pubitemid 16134711)
18. Nikolai TF, Brosseau J, Ketrick MA, et al. Lymphocytic thyroiditis with spontaneously resolving hyperthyroidism (silent thyroiditis). Arch Intern Med. 1980;140:478-482. (Pubitemid 10156648)
19. Sawin CT, Geller A, Wolf PA, et al. Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. N Engl J Med. 1994;331:1249-1252. (Pubitemid 24333188)
20. Cappola AR, Fried LP, Arnold AM, et al. Thyroid status, cardiovascular risk, and mortality in older adults. JAMA. 2006;295:1033-1041.
21. Bell GM, Sawers JS, Forfar JC, et al. The effect of minor increments in plasma thyroxine on heart rate and urinary sodium excretion. Clin Endorinol. 1983;18:511-516. (Pubitemid 13112177)
22. Biondi B, Fazio S, Coltorti F, et al. Re-entrant atrioventricular nodal tachycardia induced by levothyroxine. J Clin Endocrinol Metab. 1998;83:2643-2645. (Pubitemid 28493754)
23. Biondi B, Fazio S, Carella C, et al. Cardiac effects of long term thyrotropinsuppressive therapy with levothyroxine. J Clin Endocrinol Metab. 1993;77:334-338. (Pubitemid 23230035)
24. Biondi B, Palmieri EA, Fazio S, et al. Endogenous subclinical hyperthyroidism affects quality of life and cardiac morphology and function in young and middle-aged patients. J Clin Endocrinol Metab. 2000;85:4701-4705. (Pubitemid 32157655)
25. Foldes J, Tarjan G, Szathmari M, et al. Bone mineral density in patients with endogenous subclinical hyperthyroidism: is this thyroid status a risk factor for osteoporosis? Clin Endocrinol. 1993;39:521-527. (Pubitemid 23323948)
26. Mudde AH, Reijnders FJ, Kruseman AC. Peripheral bone density in women with untreated multinodular goiter. Clin Endocrinol. 1992;37:35-39.
27. Lervasi G, Molinaro S, Landi P, et al. Association between increased mortality and mild thyroid dysfunction in cardiac patients. Arch Intern Med. 2007;167:1526-1532. (Pubitemid 47124183)
28. Haentjens P, Van Meerhaeghe A, Poppe K, et al. Subclinical thyroid dysfunction and mortality: an estimate of relative and absolute excess all-cause mortality based on time-to-event data from cohort studies. Eur J Endocrinol. 2008;159:329-341.
29. Parle JV, Franklyn JA, Cross KW, et al. Prevalence and follow-up of abnormal thyrotrophin (TSH) concentrations in the elderly in the United Kingdom. Clin Endocrinol (Oxf). 1991;34:77-83.
30. Marqusee E, Hadan ST, Utiger RD. Subclinical thyrotoxicosis. Endocrinol Metab Clin North Am. 1998;27:37-49. (Pubitemid 28144952)
31. Tollin SR, Fallon EF, Mikhail M, et al. The utility of thyroid nuclear imaging and other studies in the detection and treatment of underlying thyroid abnormalities in patients with endogenous subclinical thyrotoxicosis. Clin Nuc Med. 2000;25:341-347. (Pubitemid 30226863)